Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
March 28, 2019 at 12:12 am
Share
Yung Zip Chemical Ind. Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 357.090 million compared to TWD 314.369 million a year ago. Operating loss was TWD 21.823 million compared to TWD 20.701 million a year ago. Net loss was TWD 14.957 million compared to TWD 24.965 million a year ago. Basic loss per share was TWD 0.35 compared to TWD 0.59 a year ago.
YUNG ZIP CHEMICAL IND. CO., LTD. is a Taiwan-based company principally engaged in the manufacturing and trading of pharmaceutical ingredient products. Its diclofenac sodium (DCS) is used for the treatment of rheumatoid arthritis, bursitis and inflammation. The acyclovir (ACV) is used for the treatment of herpes virus infections. The miconazole nitrate (MCN) is used for the treatment of yeast infection. The sodium starch glycolate (SSG) is used as disintegrant in pharmaceutical preparation. The Clonidine hydrochloride (CLD) is used for the treatment of hypertension. The Company mainly distributes its products in domestic market and overseas markets, including the United States of America (the USA), Thailand, Indonesia and the Philippines.
YUNG ZIP CHEMICAL IND. CO., LTD. 
